PVP-13055-54245
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 282 / NC
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2021-01-02
Registered in v-safe
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · Site: PainFree text: Moderate Headache 12/29 and 12/30/20MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-12
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-10
- 2021-02-19
- 2021-02-24
- 2021-03-03
- 2021-04-21
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold, congestion.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-28
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-09
-
2022-01-22
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Pregnancy test positive — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: A positive pregnancy test in November 2021 and then a miscarriage at 10 weeks in January 2022.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-28 | Unsuccessful | |
| 2022-01-22 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Moderate Headache 12/29 and 12/30/20
Release 9 — 6 months, dose 2
Symptoms: Cold, congestion.
Release 11 — 12 months, dose 2
Symptoms: A positive pregnancy test in November 2021 and then a miscarriage at 10 weeks in January 2022.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Pregnancy test positive | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release